HR
NVO

Hardy Reed’s Novo Nordisk NVO Stock Holding History

Hardy Reed’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,177
Closed -$365K – 253
2025
Q4 		$365K Buy
7,177
+90
+1% +$4.6K 0.03% 176
2025
Q3 		$393K Sell
7,087
-1,445
-17% -$84.6K 0.03% 165
2025
Q2 		$589K Buy
8,532
+238
+3% +$16.2K 0.05% 126
2025
Q1 		$576K Sell
8,294
-56
-0.7% -$4.63K 0.05% 121
2024
Q4 		$718K Sell
8,350
-1
-0% -$108 0.06% 108
2024
Q3 		$994K Buy
8,351
+2
+0% +$267 0.09% 95
2024
Q2 		$1.19M Buy
+8,349
New +$1.11M 0.12% 86

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hardy Reed's NVO Position: Q1 2026 in Review

Hardy Reed sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 7,177 shares — an estimated $365K sold.

Hardy Reed first reported a position in NVO in Q2 2024 and held it in 7 quarters. The position peaked at $1.19M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Hardy Reed reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Hardy Reed sold 7,177 Novo Nordisk shares in Q1 2026, an estimated $365K.
  • Hardy Reed first reported a position in Novo Nordisk in Q2 2024 and held it in 7 quarters.
  • Hardy Reed's Novo Nordisk position peaked at $1.19M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.